Latest Research Collaboration News

First Graphene has signed a three-year agreement with Turkish manufacturer Aeropreg to develop and potentially commercialise PureGRAPH-enhanced carbon fibre prepreg. The partnership offers a clearer route into aerospace, defence and automotive supply chains, but commercial launch remains dependent on trial results.

Locksley Resources has halted active field exploration across its Mojave antimony and rare earths project after antimony prices fell more than 57% from mid-2025 peaks. The strategic reset came as the company reported a widened FY26 loss of A$15.65 million and shifted attention to copper-gold assets in New South Wales.

Pure Resources finished 2026 with $3.67 million in cash and no debt after raising $4.7 million, but its annual loss widened as it shifted from explorer to a Garnet Hills-led advanced materials platform. The company is now pursuing garnet abrasives, jumbo flake graphite and heavy rare earth recovery through US research and defence partnerships.

Basin Energy has secured a three-year research collaboration with James Cook University to investigate improved extraction and recovery of heavy rare earths at its Sybella-Barkly project. The deal carries no cash payment, but JCU will own the resulting project intellectual property and data.

Australian Rare Earths has extended its Overland carbonatite discovery roughly 5km south, with hole OV176 intersecting 130 metres of interpreted carbonatite and ending within the unit. The geological footprint now appears to track a 10km magnetic corridor, but assays will determine whether the system carries meaningful niobium and rare earth grades.

ClearVue Technologies saw a 35% revenue decline to $161,000 and a $11 million net loss in FY2026, driven by a major operational overhaul and significant product certification efforts. Despite the financial setback, the company expanded into new markets and secured key commercial projects.

MyEco Group has trimmed its net loss by 8.1% in FY26, driven by a strategic shift toward higher-margin sustainable consumer products and operational cost savings. Australian retail sales surged 22.7%, underpinning a stronger revenue mix and improved cash flow.

Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.

RooLife Group (ASX:RLG) has completed a strategic acquisition to bolster its renewable energy division, acquiring project origination and delivery assets in the battery storage and hybrid power market. The deal is scrip-based, with most consideration contingent on future contract milestones.

Control Bionics has achieved FDA registration for its NeuroStrip surface EMG platform, cementing its medical device status in the US and bolstering its appeal in clinical and research markets.

Venus Metals Corporation (ASX:VMC) has fortified its balance sheet with a $47 million sale of its Youanmi Gold Project royalty, rebuffed a hostile takeover, and set in motion significant shareholder returns including a $35 million cash dividend.

1414 Degrees secured $8.45 million funding and inked major agreements to commercialise its SiNTL battery technology across AI data centres, drones, satellites and defence sectors.